Article Details

Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug

Retrieved on: 2021-10-21 11:53:07

Tags for this article:

Click the tags to see associated articles and topics

Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug. View article details on hiswai:

Excerpt

The neuroscience drugmaker said Wednesday that it expects Aduhelm sales to accelerate after that decision. In the meantime, company executives ...

Article found on: www.kob.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up